Use of <scp><sup>18</sup>F</scp>‐fluorodeoxyglucose Positron Emission Tomography to Monitor Disease Activity in Patients With Giant Cell Arteritis on Tocilizumab
FDG-PET has limited value to guide management decisions or inform prognosis when obtained during remission in patients with GCA on tocilizumab. Compared to glucocorticoid monotherapy, tocilizumab significantly reduces, but often does not eliminate, vascular inflammation in GCA.
Authors
- Kaitlin A. Quinn (ORCID: https://orcid.org/0000-0002-5794-194X)
- Mark A. Ahlman (ORCID: https://orcid.org/0000-0003-3906-2084)
- Peter C. Grayson (ORCID: https://orcid.org/0000-0002-8269-9438)
Institutions
- Augusta University (US)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)
Publication Details
- Journal
- ACR Open Rheumatology
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/acr2.11797
- Citations
- 3
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases